Paul De Cannière

Manager

1 past transactions

CellRev

Seed Round in 2022
CellRev is a biotechnology company focused on process intensification within cell manufacturing applications. The company’s proprietary technology facilitates the transition from batch to continuous processing of adherent cells. It’s a disruptive new biomanufacturing approach that increases yield while decreasing operating costs and capital expenditure. A proprietary cell detachment process is complemented by a specially designed bioprocess; together, they pose an altogether unique cell manufacturing solution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.